CREB1 and cancer: Increased activity of CREB has been observed in cancer cells, chronic inflammatory or neuropathic pain conditions, and blocking CREB can inhibit cell proliferation, differentiation and survival, as well as peripheral neuropathy [93,94,95,96] (Figure 1).